BANGLADESH’S pharmaceutical industry is at a defining moment. From humble beginnings in the early 1980s, when the market was valued at just USD 25 million, the sector grew into a USD 3 billion industry by 2020 and is projected to surpass USD 6 billion by 2026. This remarkable trajectory reflects not only rising domestic demand but also strategic investments in technology, infrastructure, and regulatory compliance.